NBXFO hybridoma cells produced both the membrane and secreted isoforms of macrophage colony-stimulating factor (M-CSF). Murine bone marrow cells stimulated by the secreted form o f M-CSF (sM-CSF) became Mac1 +, Mae+, Ma&+, and F4/80+ macrophages that inhibited the growth of NBXFO cells, but not L1210 or P815 tumor cells. In cytotoxicity studies, M-CSF activated macrophages and freshly isolated macrophages killed NBXFO cells in the presence of polymyxin B, eliminating the possibility that contaminating lipopolysaccharide (LPS) was responsible for the delivery of the cytotoxic signal. Retroviral-mediated transfection of T9 glioma cells with the gene for the membrane isoform of M-CSF (mM-CSF), but not for the secreted isoform of M-CSF, transferred the ability of macrophages t o kill these transfected T9 cells in a mM-CSF dose-dependent manner. Macrophage-mediated killing of the ACROPHAGES PLAY a complex role in tumor biology; their presence within a tumor can either correlate with tumor destruction or tumor growth.'-4 Macrophages become cytotoxic for tumor cells in a two-step p r o~e s s .~.~ Cytokines such as interferon-y (IFN-Y),~ granulocyte-macrophage colony-stimulating factor (GM-CSF),' tumor necrosis factor (TNF),9 and macrophage colony stimulating factor (M-CSF also known as colony stimulating factor-l, CSFinitially prime the macrophages. A secondary triggering signal is supplied either by an antibody or lipopolysaccharide (LPS) so that the macrophages can kill the tumor cell in a process that takes between 12 to 24 hours. Possible mediators of tumor cytotoxicity include: TNF, oncostatin-M, hydrogen peroxide, reactive oxygen intermediates, reactive nitrogen intermediates, direct phagocytosis or a combination of all the above.""' M-CSF is coded by one gene, but due to alternative splicing routes, different forms of M-CSF are produced.'",2" The first 5 exons are common to all forms of M-CSF. Within exon 6, an alternative splicing segment allows a region that codes for a protease sensitive protein to be deleted. This alternatively spliced 1.6 kb mRNA is translated into the mM-CSF transfected clone was blocked by using a 100-fold excess of recombinant M-CSF. Catalase, superoxide dismutase, and the nitric oxide inhibitor, Nunitro-arginine methyl ester (NAME), did not effect macrophage cytotoxicity against the mM-CSF transfectant T9 clones. T9 parental cells when cultured in the presence of an equal number of the mM-CSF transfectant cells were not killed, indicating specific target cell cytotoxicity by the macrophages. Electron microscopy showed that macrophages were capable of phagocytosizing mM-CSF bearing T9 tumor cells and NBXFO hybridoma cells; this suggested a possible mechanism of this cytotoxicity. This study indicates that mM-CSF provides the necessary binding and triggering molecules through which macrophages can initiate direct tumor cell cytotoxicity. isoform of M-CSF that stays attached to the membrane (m" CSF) for extended periods of time. Transfection experiments with the mM-CSF gene by Stein et al" showed that this isoform was a functional molecule because paraformaldehyde-fixed cells stimulated macrophage colony formation when coincubated with bone marrow stem cells. The true physiological significance of this isoform is not currently known. Alternatively, if the mRNA is processed into either the 4 kb or 2.3 kb mRNA, the protein has retained the proteolytic sensitive site that will be cut within the secretory vesicle. This cut M-CSF protein will be released from the cell when the secretory vesicle fuses with the membrane. This secreted form of M-CSF (sM-CSF) then stimulates cells in either autocrine, paracrine, or endocrine manners. Many different cells including several tumor types are known to produce M-CSF" and this cytokine may be responsible for the presence of macrophages within the tumor.
M
In preliminary studies, we discovered that NBXFO hybridoma cells (16 X 10' cells injected intraperitoneally (IP) per syngeneic mouse) did not develop tumors, even if the mice were first immunosuppressed with high-dose cyclophosphamide (300 mgkg), which induced potent macrophage suppressor We previously identified that NBXFO cells produced both the secreted and membrane forms of M-CSF." Bone marrow cells stimulated with the secreted form of M-CSF (sM-CSF) became macrophages that directly killed the NBXFO cells without the use of exogenous LPS. We tested the hypothesis that the membrane isoform of M-CSF (mM-CSF) present on tumor cells could provide a recognition molecule for macrophages to induce direct tumor cytotoxicity. By using retroviral gene transfer technology, we provide evidence that macrophages kill tumor cells expressing the membrane isoform of M-CSF.
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CA) who purchased these animals from Harlan Sprague-Dawley (San Diego, CA).
Cell lines. Mycoplasma free cells as determined using the GenProbe assay (Fisher Scientific, Tustin, CA) were grown either in RPM-1640 media supplemented with 5% fetal bovine serum (Hyclone, Logan, UT) or in a macrophage serum free media (endotoxin levels were undetectable; GIBCO, Grand Island, NY) for 2 to 4 days as a monolayer until confluence, when they were passaged 1:6. The conditioned media were saved and filter-sterilized through 0.22 pm filters. The NBXFO cells were obtained from Dr Beverly Barton (Schering-Plough, Kenilworth, NJ); while the L1210 cells were obtained from Dr Lewis Slater (Department of Pathology, University of California, Irvine, CA). T9 glioma cells were obtained from M. Graf and Dr J. Hiserodt (Departments of Molecular Biology and Pathology, University of California, Irvine, CA). The P815, PA317, and WEHI-3 cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD).
The hybridomas producing monoclonal antibodies against murine Mac l a (TIB 128), Mac 2 (TIB 166), Mac 3 (TIB 168), and F4180 (HB 198) were purchased from the American Type Culture Collection. The supernates derived from NBXFO and M-CSF transfected clones were filtered through 0.22 p filters and were used at 25% to 33% concentrations to stimulate the growth of either murine macrophages or rat macrophages.
Bone marrow macrophage cultures. Bone marrow cells were cultured in 33% M-CSF containing conditioned media for 1 week at 37°C in a humidified 5% COz atm~sphere.'~ Initial work with the NBXFO cells was done in RPMI-1640 media with 5% fetal bovine serum (Hyclone) and using NBXFO supernate as the source of M-CSF. The work using rat macrophages was done with macrophage serum-free media (GIBCO) using M-CSF transfectant supernate as the source of M-CSF. After 1 week, the media was replaced with fresh 33% conditioned media. All culture materials were disposable plastics and free of endotoxin. Macrophages were removed by washing off the tissue culture media, and then incubating the cells in clinical grade imgation saline (Kendal McGaw Inc, Irvine, CA) for 30 minutes to 1 hour at 4°C. The cells were scraped using a cell scraper. This procedure results in >95% viability of the macrophages.
Construction of amphotropic retroviruses to transfer the M-CSF isoforms. The production of amphotropic retroviruses has been previously described in detail in Nolta et al.25. The cDNA genes encoding for functional human M-CSF both the membrane-isoform and the secreted-isoform contained in pBR325 plasmids were obtained from Dr Carl Rettenmier (Children's Hospital of Los Angeles, Los Angeles, CA)" after Materials Transfer Agreements were signed with Chiron Corporation (Emoryville, CA). The M-CSF genes were excised using Xho I and then ligated into the Xho I site of the pLXSN shuttle vector.27 These plasmids transformed DH5a bacteria and were selected in 50 pg/mL ampicillin. Aliquots of various plasmid clonal isolates were then digested with various restriction enzymes to insure that the M-CSF genes were oriented in the sense position. Plasmids containing the proper gene orientation were then used to transfect GPE cells via DOTAP (Boehringer-Mannhiem, Indianapolis, IN) to produce ecotropic retrovirus?' After 2 days, the supernates from these retroviruses were used to infect PA317 cells.29 Cells were selected in 1 mg/mL G418 (Geneticin, GIBCO) for 1 week. Afterwards, the PA3 17 cells that were resistant to G41 8 were cloned. Clones of PA3 17 producing high titers of retrovirus ( IO5 to lo6 infectious unitslml) were selected and tested for functional retroviral activity.
Transfection of M-CSF genes into tumor cells. Rat T9 glioma cells were infected in six-well cluster dishes (Coming, Corning, NY). One hundred thousand exponentially growing cells were incubated either in the presence or absence of the supernates of the retroviruses overnight. The cells were refed with fresh media containing 1 mg/mL G418. After 2 weeks of G418 selection, cells that were not infected with any retrovirus died, whereas, the infected cells continued to grow. Cells were selected based on production of human M-CSF using the human M-CSF Quantikine kits (R&D Systems, Minneapolis, MN). For sM-CSF production, cells were grown at IO5 cells/mL for 3 days and then tested. For m"CSF detection, cells were tested by flow cytometric analysis as described below.
Antibodies and flow cyzornetty. Cells to be phenotyped were first incubated in phosphate-buffered saline (PBS) for 10 minutes, followed by a 5 to IO-minute incubation at 37°C with 1 mg/mL collagenase (Sigma Chemical, St Louis, MO). After cells detached from the plastic, they were centrifuged and resuspended in PBS and counted. One-half million cells in 50 pL were first incubated with 25 pL of normal rabbit serum for 5 minutes on ice to saturate all membrane bound Fc receptors followed by an incubation with 2. Hybridoma cells producing monoclonal antibodies against the murine Mac-l, Mac-2, Mac-3, and F4/80 determinants were purchased from ATCC. These cells were grown in vitro, and then the antibodies were isolated using the affinity purification reagents available from Sigma Chemical. Monoclonal antibodies against rat macrophage determinant ED1 was purchased from Harlan Bioproducts for Science (Indianapolis, IN).
Cytostasis and cytotoxicity studies. Macrophages used for both types of experiments were first treated with 100 pg/mL of mitomycin-C (Sigma Chemical CO) for 1 hour at 37°C to prevent macrophage-mediated division in these 'H-thymidine-based assays. Macrophage-mediated cytostasis experiments were performed using the procedure of Krahenbuhl and Rernington?' in 96 flat well plates. Here macrophages were incubated at various ratios with the tumor cells starting at 2.1 and finishing at 0.25:l. Fifty thousand tumor cells were plated with the macrophages in a final volume of 200 pL of macrophage serum-free media. On the next day, 8 hours before harvesting the cells, the individual wells were pulsed with 1 pCi of 'H-thymidine ('H-TdR; New England Nuclear, NET-O27A, 74 GBq/ m o l ) in a volume of 25 pL. Immediately before the cultures were harvested, cultures were viewed under an inverted microscope to confirm whether tumor cells were present or absent under the various experimental conditions. Cells were then aspirated through a glass wool fiber filter with a multiple sample harvester (PhD Harvester, Cambridge, MA), and total 'H-TdR incorporation was determined by liquid scintillation procedures using Bio-Safe I1 (Research Products Int, Mount Prospect, IL). Data are expressed as the mean counts per minute (CPM) 2 standard deviation (SD) per triplicate culture. Visual observations from each experiment confirmed the cytostasis results.
Macrophage mediated cytotoxicity studies were performed according to the method of Meltzer.'' Target tumor cells were labeled with 4 pCi of 'H-TdR overnight in the media. The next morning, tissue culture media was replaced with fresh media and allowed to incubate a further 1 to 3 hours to reduce spontaneous release by the tumor cells. of macrophage serum-free media overnight with graded doses of macrophages ranging from IO: 1 to 0.75: I at 37°C in a humidified 5% CO2 incubator. Immediately before the supernates were harvested, cultures were viewed under an inverted microscope to confirm whether tumor cells were present or absent under the various experimental conditions. Afterwards, 100 pL of supernate was removed and placed into 2 mL of scintillation fluid. Spontaneous release after 24 hours was about 10% of maximum release. Maximum release is calculated by taking IO4 target cells and freeze-thawing them three times in liquid nitrogen. Specific release is calculated using the standard equation for cytotoxicity reactions.'2,'3 Visual observations from each experiment confirmed the cytotoxicity results. Cytotoxicity data from multiple experiments were pooled together at each macrophage: tumor cell ratio and is then presented as the mean 2 standard of the error of the means. Cytotoxicity is not considered relevant if values are ~1 0 % specific release.
Data from the cytostasis and cytotoxicity assays were analyzed using Student's t tests on the Sigma Plot Version 5.0 (Jandel Scientific, San Rafael, CA) computer program. Values were considered significantly different at the P < 0.05 levels.
Clinical grade Cetus M-CSF (activity: 6.94 X IO' unitslmg; endotoxin content <0.08 EUlmL) was kindly provided by Chiron Corporation (Emoryville, CA).
Electron microscopic studies.
Cells were gently scraped from monolayer cultures and then centrifuged (1.OOOg) in a 15-mL centrifuge tube for 10 minutes. The cells were then prepared the same way as described in detail in Jadus et al.24.32 The grids were examined with a Joel Electron microscope (Peabody, MA). Figure 3 demonstrated that the bone marrow derived macrophages killed NBXFO cells in cytotoxicity assays. We used 30 pg/ mL polymyxin-B to bind any endotoxin that could have contaminated the media or the cells. This data was pooled together at each effector:target ratio from eight independent assays. M-CSF-activated macrophages from two separate experiments did not kill NIH 3T3 cells transfected with the human mM-CSF gene. By flow cytometric analyses, these mM-CSF-transfected 3T3 cells were >90% for mM-CSF. This indicates that only tumor cells with the mM-CSF phenotype are killed by these macrophages.
RESULTS

M-CSF-activated bone marrow-derived macrophages in-
Freshly isolated adherent cells also kill NBXFO cells. We took adherent cells obtained from murine bone marrow and spleen and assayed them to determine if freshly isolated macrophages could kill NBXFO cells. exposure to M-CSF are capable of killing these target cells. Thymocytes did not kill the NBXFO cells, eliminating the trivial possibility that physical overcrowding was responsible for the death of the NBXFO cells.
Transfected tumor cells displaying mM-CSF are killed by M-CSF activated macrophages. The previous studies suggested that macrophages killed NBXFO cells by recognizing the mM-CSF found on NBXFO cells. Because NBXFO cells are hybridoma cells and may have other molecules that could provide macrophages with other ligands for binding, we performed more definitive experiments using T9 glioma cells expressing m"CSF.
Rat T9 glioma cells were infected with retroviruses constructed to transfect the genes for either the membrane isoform or the secreted isoform of human M-CSF (sM-CSF). Transfected cells were selected in G418 for 2 weeks and subsequently cloned. Figure 4 shows the cell surface m" CSF phenotype of three randomly chosen T9 mM-CSF transfectant clones (C2, F2, F6) along with 1 sM-CSF transfected clone (Hl, by culturing 10' cells/mL for 3 days these cells produced >2,000 pg/mL). By flow cytometry, the T9 parental cells and the H1 clone showed negligible mM-CSF positivity, 0.29% and 0.46%, respectively. The m"CSF transfectant clones all expressed m"CSF, but to variable amounts. The C2 clone was the most fluorescent, while the F6 clone was the least fluorescent.
Rat bone marrow derived macrophages (>90% ED1 i) 5235 were tested for their ability to kill these transfected T9 cells in Fig S. The macrophages killed the mM-CSF infected clones in a m"CSF concentration-dependent manner. The C2 clone was killed the best, followed by the F2 clone. The F6 clone was not killed any better than were H1 or the T9 parental cells. Thus, there is a required threshold amount of mM-CSF present on the target cell before the macrophages will kill that target cell. We selected the C2 and H1 clones for all further work. The macrophages have reproducibly killed only the C2 cells and not H1 or the parental cells. We modified the M-CSF enzyme-linked immunosorbent assay (ELISA) assay to quantitate the amount of mM-CSF present on C2 cells (Jadus et al, manuscript submitted) We found that 10,000 C2 cells express 1,002 pg of mM-CSF, while an equivalent number of H1 clones or parental T9 cells were negative for m"CSF. We used a 100-fold excess of M-CSF (100,000 pp) to completely block macrophage cytotoxicity against the C2 clones as shown in Table 2 . This experiment has been successfully reproduced one more time.
The mechanism of cytotoxicity displayed by the macrophages against the mM-CSF transfectant C2 clone does not involve a soluble factor, but may include phagocytosis. Tumoricidal macrophages can kill through the production of short-lived soluble factors such as superoxide radicals, hydrogen peroxide, and nitric oxide. We tested whether inhibitors of these cytotoxins could prevent macrophage-mediated killing of the C2 clones. Figure 6 shows that SO U/mL of catalase, 20 U/mL superoxide dismutase, and 20 pmoVL NAME failed to prevent macrophage-mediated killing of the C2 clones (upper panel). All experimental results at each macrophage:tumor ratio were not significantly different ( P > .OS) from the untreated control cells. None of these reagents affected macrophage cytotoxicity of the parental T9 cells or H1 clones (lower two panels).
To eliminate the possibility that other unknown soluble cytotoxins are responsible for this macrophage-mediated cytotoxicity against the m"CSF clones, we performed mixing experiments. Here labeled T9 or H1 clones were mixed with an equal number of unlabeled m"CSF C2 cells in the presence of the bone marrow-derived macrophages. In Table 3 , the macrophages did kill the m"CSF C2 clone, but the macrophages did not kill the labeled parental T9 or H1 clone, either alone or in the presence of the unlabeled C2 clone. This study eliminates that any soluble cytotoxic factor such as TNF, oncostatin-M, or interferon could be released by the cytotoxic macrophages.
This last experiment suggested that cell-to-cell contact was required for this specific cytotoxicity. We performed electron microscopy to determine whether phagocytosis could be responsible for this cytotoxicity. Figure 7A shows a typical T9 cell, while Fig 7B shows a typical rat bone marrow-derived macrophage cultured in macrophage serumfree media in the presence of M-CSF derived form HI cells M-CSF (100.000 pg) was added to achieve a 100-fold excess.
For
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DISCUSSION
In tumor biology, macrophages may be considered a ''double edged sword". Macrophages frequently associate within breast and ovarian tumors in response to M-CSF produced by these tumor^?^-^' Macrophages may induce tumor growth by releasing stimulatory or angiogenic factors or by acting as immunosuppressor cells?943 Other studies have concluded that macrophages were beneficial for the host.449 In several cytokine transfection models, macrophages were one effector cell when the tumor cells were expressing interleukin-2 (L-2):' L-4:' L-6:' IL-7,53 and TNF?5 For macrophages to become tumoricidal in vitro, they must be stimulated in two ways?*6 First, cytokines prime the macrophages, while secondary signals allow the macrophage to kill the tumor cell. It is tempting to speculate that this "double edged sword" effect could be explained by the twosignal model. When macrophages only receive the priming signal, these macrophages promote tumor growth and metastases. Whereas, when both signals are received the macrophages mediated tumor regression. One possible mechanism to tip the balance toward a favorable prognostic response is to devise a molecule that delivers to the macrophage both cytotoxic delivery signals simultaneously. In studies presented here, macrophage cytotoxicity against tumor cells may be accomplished by a single molecule, namely the membrane isoform of macrophage colony stimulating factor.
In this report, we found that M-CSF-activated macrophages inhibited the growth of m"CSF expressing NBXFO cells (Fig 2) and killed NBXFO cells in an endotoxin-free environment (Fig 3) . NBXFO for 2 weeks. The macrophage contained numerous granules. Additionally, these cells possessed several lipid droplets. These fat droplets provided us with a fortunate internal marker for the macrophages so we can positively identify the macrophage when we mixed these cells with the T9 tumor cells. Figure 7C shows a macrophage that was incubated with the m"CSF transfectant cells after 24 hours. Here a macrophage has ingested several m"CSF transfected T9 tumor cells (labeled T). The macrophage is identified because the macrophage is the bigger cell, and the lipid droplets are present. These lipid droplets have coalesced into bigger ones. The numerous granules found in the normal macrophage have disappeared in these phagocytic macrophages. Presumably these granules fused with the m"CSF bearing tumor cells when they formed the phagolysosome.
To determine whether phagocytosis could be responsible for the cytotoxicity observed against NBXFO cells. We also performed electron microscopy with the murine macrophages and NBXFO cells. Again, we found macrophages that ingested NBXFO cells, one such cell is shown in Fig  8. These murine macrophages were previously cultured in complete RPMI-I640 media along with the NBXFO supernate and did not display any fat droplets as seen in the rat macrophages when cultured in the macrophage serumfree media. This study illustrates that the presence of fat droplets within the-macrophages are not necessary for macrophage cytotoxicity. Rat T9 glioma clones transfected with the mM-CSF retrovirus, did express mM-CSF (Fig 4) and were killed by M-CSF activated macrophages in a dose-dependent juxtacrine manner (Fig 5) . Parental T9 cells and sM-CSF transfected HI clones were not killed by these macrophages. This macrophage-mediated cytotoxicity against the m"CSF transfectant was prevented by using a 100-fold excess of recombinant M-CSF ( Table 2) . NIH 3T3 fibroblasts expressing mM-CSF were not killed by macrophages (Fig 3) . Membrane M-CSF by itself is insufficient to allow macrophages to kill nontransformed cells bearing this molecule. Therefore, another tumor specific molecule allows the macrophages to distinguish the tumor cell from a normal cell. This finding In summary, we have found that M-CSF activated macrophages inhibited the growth and killed NBXFO hybridoma cells that express the membrane isoform of macrophage colony-stimulating factor. This cytotoxic activity was mediated by both M-CSF-activated bone marrow-derived macrophages and freshly isolated macrophages. When T9 glioma cells were transfected with retroviruses containing the gene for mM-CSF, macrophages killed those T9 glioma cells that only expressed the mM-CSF. This killing was inhibited by using a 100-fold excess of recombinant M-CSF. One putative mechanism of macrophage mediated killing may include direct phagocytosis of the mM-CSF tumor cells, because no evidence that a soluble cytotoxic mediator was found.
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